COMPREHENSIVE THERAPIES LIMITED

Company Registration Number:
06948168 (England and Wales)

Unaudited statutory accounts for the year ended 30 June 2023

Period of accounts

Start date: 01 July 2022

End date: 30 June 2023

COMPREHENSIVE THERAPIES LIMITED

Contents of the Financial Statements

for the Period Ended 30 June 2023

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

COMPREHENSIVE THERAPIES LIMITED

Company Information

for the Period Ended 30 June 2023




Director: Andrew Harpham-Salter
Alison Harpham-Salter
Secretary: Andrew Harpham-Salter
Registered office: Room 6 The Manor House
Lutyens Close
Chineham
Basingstoke
England
RG24 8AG
Company Registration Number: 06948168 (England and Wales)

COMPREHENSIVE THERAPIES LIMITED

Balance sheet

As at 30 June 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 4 39,119 43,381
Total fixed assets: 39,119 43,381
Current assets
Debtors: 5 42,254 15,526
Cash at bank and in hand: 90,803 113,336
Total current assets: 133,057 128,862
Prepayments and accrued income: 600 2,510
Creditors: amounts falling due within one year: 6 ( 14,805 ) ( 51,216 )
Net current assets (liabilities): 118,852 80,156
Total assets less current liabilities: 157,971 123,537
Total net assets (liabilities): 157,971 123,537

The notes form part of these financial statements

COMPREHENSIVE THERAPIES LIMITED

Balance sheet continued

As at 30 June 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 400 400
Profit and loss account: 157,571 123,137
Shareholders funds: 157,971 123,537

For the year ending 30 June 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 16 April 2024
And Signed On Behalf Of The Board By:

Name: Andrew Harpham-Salter
Status: Director

The notes form part of these financial statements

COMPREHENSIVE THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

COMPREHENSIVE THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 2 1

COMPREHENSIVE THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

  • 3. Off balance sheet disclosure

    No

COMPREHENSIVE THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

4. Tangible assets

Plant & machinery Office equipment Total
Cost £ £ £
At 01 July 2022 70,738 5,750 76,488
Additions 6,377 - 6,377
Disposals - - -
Revaluations - - -
Transfers - - -
At 30 June 2023 77,115 5,750 82,865
Depreciation
At 01 July 2022 29,648 3,459 33,107
Charge for year 9,493 1,146 10,639
On disposals - - -
Other adjustments - - -
At 30 June 2023 39,141 4,605 43,746
Net book value
At 30 June 2023 37,974 1,145 39,119
At 30 June 2022 41,090 2,291 43,381

COMPREHENSIVE THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

5. Debtors


2023
£

2022
£
Other debtors 42,254 15,526
Total 42,254 15,526

COMPREHENSIVE THERAPIES LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2023

6.Creditors: amounts falling due within one year note


2023
£

2022
£
Trade creditors 40,000
Taxation and social security 14,805 11,150
Accruals and deferred income 66
Total 14,805 51,216